These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10677236)

  • 1. Alpha-ketoacids are potent slow binding inhibitors of the hepatitis C virus NS3 protease.
    Narjes F; Brunetti M; Colarusso S; Gerlach B; Koch U; Biasiol G; Fattori D; De Francesco R; Matassa VG; Steinkühler C
    Biochemistry; 2000 Feb; 39(7):1849-61. PubMed ID: 10677236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prime site binding inhibitors of a serine protease: NS3/4A of hepatitis C virus.
    Ingallinella P; Fattori D; Altamura S; Steinkühler C; Koch U; Cicero D; Bazzo R; Cortese R; Bianchi E; Pessi A
    Biochemistry; 2002 Apr; 41(17):5483-92. PubMed ID: 11969409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition and binding kinetics of the hepatitis C virus NS3 protease inhibitor ITMN-191 reveals tight binding and slow dissociative behavior.
    Rajagopalan R; Misialek S; Stevens SK; Myszka DG; Brandhuber BJ; Ballard JA; Andrews SW; Seiwert SD; Kossen K
    Biochemistry; 2009 Mar; 48(11):2559-68. PubMed ID: 19209850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzymatic characterization of membrane-associated hepatitis C virus NS3-4A heterocomplex serine protease activity expressed in human cells.
    Hamill P; Jean F
    Biochemistry; 2005 May; 44(17):6586-96. PubMed ID: 15850392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitor binding induces active site stabilization of the HCV NS3 protein serine protease domain.
    Barbato G; Cicero DO; Cordier F; Narjes F; Gerlach B; Sambucini S; Grzesiek S; Matassa VG; De Francesco R; Bazzo R
    EMBO J; 2000 Mar; 19(6):1195-206. PubMed ID: 10716920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probing the active site of the hepatitis C virus serine protease by fluorescence resonance energy transfer.
    Fattori D; Urbani A; Brunetti M; Ingenito R; Pessi A; Prendergast K; Narjes F; Matassa VG; De Francesco R; Steinkühler C
    J Biol Chem; 2000 May; 275(20):15106-13. PubMed ID: 10809747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMR line-broadening and transferred NOESY as a medicinal chemistry tool for studying inhibitors of the hepatitis C virus NS3 protease domain.
    LaPlante SR; Aubry N; Bonneau PR; Kukolj G; Lamarre D; Lefebvre S; Li H; Llinàs-Brunet M; Plouffe C; Cameron DR
    Bioorg Med Chem Lett; 2000 Oct; 10(20):2271-4. PubMed ID: 11055336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Product inhibition of the hepatitis C virus NS3 protease.
    Steinkühler C; Biasiol G; Brunetti M; Urbani A; Koch U; Cortese R; Pessi A; De Francesco R
    Biochemistry; 1998 Jun; 37(25):8899-905. PubMed ID: 9636031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural characterization of the interactions of optimized product inhibitors with the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein by NMR and modelling studies.
    Cicero DO; Barbato G; Koch U; Ingallinella P; Bianchi E; Nardi MC; Steinkühler C; Cortese R; Matassa V; De Francesco R; Pessi A; Bazzo R
    J Mol Biol; 1999 Jun; 289(2):385-96. PubMed ID: 10366512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of charged residues in the catalytic mechanism of hepatitis C virus NS3 protease: electrostatic precollision guidance and transition-state stabilization.
    Koch U; Biasiol G; Brunetti M; Fattori D; Pallaoro M; Steinkühler C
    Biochemistry; 2001 Jan; 40(3):631-40. PubMed ID: 11170379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution, synthesis and SAR of tripeptide alpha-ketoacid inhibitors of the hepatitis C virus NS3/NS4A serine protease.
    Colarusso S; Gerlach B; Koch U; Muraglia E; Conte I; Stansfield I; Matassa VG; Narjes F
    Bioorg Med Chem Lett; 2002 Feb; 12(4):705-8. PubMed ID: 11844706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus NS3/4A protease.
    Kwong AD; Kim JL; Rao G; Lipovsek D; Raybuck SA
    Antiviral Res; 1999 Feb; 41(1):67-84. PubMed ID: 10321580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational changes in human hepatitis C virus NS3 protease upon binding of product-based inhibitors.
    Bianchi E; Orrù S; Dal Piaz F; Ingenito R; Casbarra A; Biasiol G; Koch U; Pucci P; Pessi A
    Biochemistry; 1999 Oct; 38(42):13844-52. PubMed ID: 10529230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanistic role of an NS4A peptide cofactor with the truncated NS3 protease of hepatitis C virus: elucidation of the NS4A stimulatory effect via kinetic analysis and inhibitor mapping.
    Landro JA; Raybuck SA; Luong YP; O'Malley ET; Harbeson SL; Morgenstern KA; Rao G; Livingston DJ
    Biochemistry; 1997 Aug; 36(31):9340-8. PubMed ID: 9235976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple determinants influence complex formation of the hepatitis C virus NS3 protease domain with its NS4A cofactor peptide.
    Urbani A; Biasiol G; Brunetti M; Volpari C; Di Marco S; Sollazzo M; Orrú S; Piaz FD; Casbarra A; Pucci P; Nardi C; Gallinari P; De Francesco R; Steinkühler C
    Biochemistry; 1999 Apr; 38(16):5206-15. PubMed ID: 10213628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the protease domain in NS3 of hepatitis C virus.
    Han DS; Hahm B; Rho HM; Jang SK
    J Gen Virol; 1995 Apr; 76 ( Pt 4)():985-93. PubMed ID: 9049347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acyl sulfonamides as potent protease inhibitors of the hepatitis C virus full-Length NS3 (protease-helicase/NTPase): a comparative study of different C-terminals.
    Johansson A; Poliakov A; Akerblom E; Wiklund K; Lindeberg G; Winiwarter S; Danielson UH; Samuelsson B; Hallberg A
    Bioorg Med Chem; 2003 Jun; 11(12):2551-68. PubMed ID: 12757723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hepatitis C virus NS3 proteinase: structure and function of a zinc-containing serine proteinase.
    De Francesco R; Pessi A; Steinkühler C
    Antivir Ther; 1998; 3(Suppl 3):99-109. PubMed ID: 10726060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of hepatitis C virus NS3 protease and helicase activities through the interaction with NS4A.
    Gallinari P; Paolini C; Brennan D; Nardi C; Steinkühler C; De Francesco R
    Biochemistry; 1999 Apr; 38(17):5620-32. PubMed ID: 10220351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HCV-NS3 inhibitors: determination of their kinetic parameters and mechanism.
    Flores MV; Strawbridge J; Ciaramella G; Corbau R
    Biochim Biophys Acta; 2009 Oct; 1794(10):1441-8. PubMed ID: 19505593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.